Wendy Ewart | |
|---|---|
 Ewart in 2010 | |
| Nationality | British |
| Alma mater | University of Southampton and the University of Bristol |
| Known for | Deputy Chief Executive and Chief of Strategy, MRC; Director of both UK Biobank and the Francis Crick Institute |
| Scientific career | |
| Institutions | Medical Research Council |
Wendy Ewart is a British scientist who worked for the Medical Research Council (MRC) from 2008 to 2014.
Ewart earned a BSc in physiology and biochemistry from the University of Southampton, and a PhD in neuroscience at the University of Bristol. [1] She was later awarded an additional honorary doctorate from the University of Bristol after her retirement. [1]
Before joining the MRC, Ewart worked at the Wellcome Trust (1991-2003) managing funding programmes, including those for the developing world. From 2003 to 2008 she was head of research strategy at the faculty of medicine, Imperial College. [2]
Ewart was appointed as director of strategy for the MRC in 2008. In this position, Ewart was responsible for the development of the MRC's strategic plan "Research Changes Lives," which was introduced in June 2009.She was appointed as Deputy Chief Executive and Chief of Strategy in January 2012. [3] In this capacity she was a director of both UK Biobank and the Francis Crick Institute. [4]
Ewart retired as the Deputy Chief Executive and Chief of Strategy for the MRC in 2014. [5] She was succeeded by Dr. Jim Smith. [5] Upon her retirement, Professor Sir John Savill, the Chief Executive of the MRC said,
“Wendy Ewart has made an enormous contribution to the MRC, achieving so much in a short period of time, and she will be greatly missed. I give her my thanks for being an outstanding deputy and wish her well.” [5]
The Medical Research Council (MRC) is responsible for co-coordinating and funding medical research in the United Kingdom. It is part of United Kingdom Research and Innovation (UKRI), which came into operation 1 April 2018, and brings together the UK's seven research councils, Innovate UK and Research England. UK Research and Innovation is answerable to, although politically independent from, the Department for Business, Energy and Industrial Strategy.
The National Institute for Medical Research, was a medical research institute based in Mill Hill, on the outskirts of north London, England. It was funded by the Medical Research Council (MRC);
Geraint Ellis Rees FMedSci is Dean of the UCL Faculty of Life Sciences, UCL Pro-Provost, UCL Pro-Vice-Provost (AI) and a Professor of Cognitive Neurology at University College London. He is also a Director of UCL Business and a trustee of the Guarantors of Brain.
Sir David Keith Peters is a retired Welsh physician and academic. He was Regius Professor of Physic at the University of Cambridge from 1987 to 2005, where he was also head of the School of Clinical Medicine.
Sir Rory Edwards Collins FMedSci FRS is a British physician who is Professor of Medicine and Epidemiology at the Clinical Trial Service Unit within the University of Oxford, the head of the Nuffield Department of Population Health and a Fellow of Green Templeton College, Oxford. His work has been in the establishment of large-scale epidemiological studies of the causes, prevention and treatment of heart attacks, other vascular disease, and cancer, while also being closely involved in developing approaches to the combination of results from related studies ("meta-analyses").
Fiona Watt, is a British scientist who is internationally known for her contributions to the field of stem cell biology. In the 1980s, when the field was in its infancy, she highlighted key characteristics of stem cells and their environment that laid the foundation for much present day research. She is currently director of the Centre for Stem Cells & Regenerative Medicine at King's College London, and Executive Chair of the Medical Research Council (MRC), the first woman to lead the MRC since its foundation in 1913. On 13 July 2021 she has been appointed as the new Director of the European Molecular Biology Organization (EMBO).
The Francis Crick Institute is a biomedical research centre in London, which was established in 2010 and opened in 2016. The institute is a partnership between Cancer Research UK, Imperial College London, King's College London (KCL), the Medical Research Council, University College London (UCL) and the Wellcome Trust. The institute has 1,500 staff, including 1,250 scientists, and an annual budget of over £100 million, making it the biggest single biomedical laboratory in Europe.
Doreen CantrellCBE, FRS, FRSE, FMedSci, is a scientist and Professor of Cellular Immunology at the School of Life Sciences, University of Dundee. She researches the development and activation T lymphocytes, which are key to the understanding the immune response.
Sir James Cuthbert Smith is Director of Science at the Wellcome Trust and Senior Group Leader at the Francis Crick Institute.
Duncan Odom is a research group leader at the German Cancer Research Center (DKFZ) in Heidelberg, and the Cancer Research UK Cambridge Institute at the University of Cambridge. Previously he was as an associate faculty member at the Wellcome Trust Sanger Institute from 2011 to 2018.
Catherine Sudlow is a British neurologist. She is a professor of Neurology and Clinical Epidemiology and Head of the Centre for Medical Informatics at the Usher Institute of Population Health Sciences and Informatics at the University of Edinburgh. She is the Chief Scientist of UK Biobank, and an honorary Consultant Neurologist in the Division of Clinical Neurosciences in Edinburgh.
Deborah A. Lawlor is a British epidemiologist and professor at the University of Bristol, where she is the deputy director of the Medical Research Council Integrative Epidemiology Unit. She is also a fellow of the Faculty of Public Health and of the Academy of Medical Sciences. Her main areas of research are perinatal, reproductive and cardio-metabolic health. Lawlor was awarded a CBE in the 2017 Queen's Birthday Honours for her services to social and community medicine research.
Kate Tilling is a British statistician who specialises in developing and applying statistical methods to overcome problems encountered in epidemiological research. Tilling has been a professor in medical statistics. in population health sciences within Bristol Medical School, University of Bristol, since 2011. She joined the University of Bristol in 2002 as a Senior Lecturer, following nine years as a lecturer at King's College London.
Virginia M. Barbour is a professor at Queensland University of Technology (QUT) in Brisbane, Australia, and serves as the Director of the Australasian Open Access Strategy Group. She is best known for being one of the three founding editors of PLOS Medicine, and her various roles in championing the open access movement.
Caetano Maria Pacheco Pais dos Reis e Sousa is a senior group leader at the Francis Crick Institute and a professor of Immunology at Imperial College London.
Leonid A. Sazanov is a professor at the Institute of Science and Technology Austria (IST). Sazanov research explores the structure and function of large membrane protein complexes from the domain of bioenergetics. These molecular machines interconvert redox energy and proton motive force across biological membranes using a variety of mechanisms.
Marta Zlatic is a Croatian neuroscientist who is group leader at the MRC Laboratory of Molecular Biology in Cambridge, UK. Her research investigates how neural circuits generate behaviour.
M. Madan Babu is an Indian-American computational biologist and bioinformatician. He is the endowed chair in biological data science and director of the center of excellence for data-driven discovery at St. Jude Children’s Research Hospital. Previously, he served as a programme leader at the MRC Laboratory of Molecular Biology (LMB).
Professor Patrick Francis Chinnery FRCP FRCPath FMedSci is a neurologist, clinician scientist, and Wellcome Trust Principal Research Fellow based in the Medical Research Council Mitochondrial Biology Unit and the University of Cambridge, where he is also Professor of Neurology and Head of the Department of Clinical Neurosciences.
Sarah Rowland-Jones is a British physician who is a Professor of Immunology at the University of Oxford. She works on immune responses to HIV infection. She has focussed her research on problems caused by HIV in Africa, with a hope to create a successful HIV vaccine. She is the former president of the Royal Society of Tropical Medicine and Hygiene.
{{cite web}}: Cite uses generic title (help)